GlaxoSmithKline Net Worth 2006-2021 | GSK

Interactive chart of historical net worth (market cap) for GlaxoSmithKline (GSK) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. GlaxoSmithKline net worth as of September 23, 2021 is $105.93B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $105.927B $43.788B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $433.991B 18.06
Pfizer (PFE) United States $247.760B 14.07
Novo Nordisk (NVO) Denmark $240.425B 33.37
Eli Lilly (LLY) United States $222.667B 28.91
AbbVie (ABBV) United States $189.724B 9.09
Novartis AG (NVS) Switzerland $186.924B 13.88
Merck (MRK) United States $184.917B 12.66